Ebola vaccine could take nine months as death toll rises further, WHO warns
WHO Warns Ebola Vaccine Development Could Take Nine Months Amid Rising Death Toll
Ebola vaccine could take nine months – The World Health Organization (WHO) has indicated that the creation of an effective vaccine against the Bundibugyo strain of Ebola could require up to nine months, according to recent assessments. This timeline comes as the virus continues to spread, prompting concerns about the pace of containment efforts. Dr Vasee Moorthy, a WHO advisor, stated on Wednesday that two potential “candidate vaccines” are currently in development for the Bundibugyo species, though neither has yet entered clinical trials. The delay in testing highlights the urgency of the situation, with officials emphasizing the need for accelerated progress.
Public Health Emergency Declared, But Not at Pandemic Level
WHO chief Dr Tedros Adhanom Ghebreyesus declared a public health emergency of international concern on Sunday, yet he clarified that the outbreak has not reached pandemic status. During a press briefing in Geneva, Tedros noted that the emergency committee had convened to evaluate the threat and concluded that the risk was “not a pandemic emergency.” However, he stressed that the organization deemed the epidemic a high priority at the national and regional levels, with the global impact still considered low. This assessment is based on the current spread and the challenges faced in controlling the outbreak.
Tedros also highlighted the growing numbers, citing 600 suspected cases and 139 suspected deaths as of the latest report. He warned that these figures are likely to increase further, as detection efforts continue. The confirmed cases include 51 in the Democratic Republic of Congo (DRC), where the first outbreak was identified, and two in Uganda. The latter cases involved individuals who had traveled from the DRC, with one of them succumbing to the virus in Kampala, the Ugandan capital. This regional spread underscores the interconnectedness of health crises across borders.
Healthcare workers in the DRC are reporting severe strain on local facilities, with some describing the situation as chaotic. Trish Newport, a Medecins Sans Frontieres (MSF) emergency programme manager, shared firsthand accounts of overwhelmed hospitals, where staff are struggling to manage the influx of patients. “Health facilities are telling us: ‘We are full of suspect cases. We don’t have any space,’” she told AFP news agency. The sentiment reflects the urgency of the moment, with frontline workers adapting to the pressures of the crisis.
The UK government has pledged £20 million in funding to support containment measures, allocating resources to frontline health workers, infection control upgrades, and enhanced disease surveillance. This financial commitment aims to bolster efforts in the DRC and surrounding areas, where the outbreak is intensifying. WHO officials are also conducting investigations to determine the duration of the virus’s spread, with the immediate focus remaining on curbing transmission. The first known case, a nurse who died on 24 April in Ituri, was identified as the origin of the outbreak, though the virus may have been circulating for longer.
Rarity of Bundibugyo Strain Poses Unique Challenges
The Bundibugyo species, which has not been reported for over a decade, is proving to be a complex adversary. Araali Bagamba, a lecturer in Bunia, the provincial capital of Ituri, described the public’s heightened awareness of the danger. “For the past three days, I haven’t shaken anyone’s hand, and I’ve noticed this behavior is becoming common among people,” she said to the BBC World Service Newsday programme. This shift in social habits reflects a growing sense of urgency and fear within communities.
While the Bundibugyo strain is less lethal than others, its rarity means fewer tools are available to combat it. Unlike the more familiar Zaire strain, which has been responsible for numerous outbreaks in the DRC, the Bundibugyo variant presents unique challenges in terms of vaccine development and public response. Currently, there is no approved vaccine for this strain, though experimental options are in progress. Some scientists suggest that a Zaire-based vaccine might offer partial protection, but this remains unconfirmed.
Dr Moorthy, speaking alongside Tedros on Wednesday, noted that one of the candidate vaccines under development “would be the equivalent of” the only existing Ebola vaccine, which is effective against the Zaire strain. He described it as a promising option for the Bundibugyo variant, though it requires further testing before it can be deployed. The second vaccine, which utilizes the same platform as the AstraZeneca vaccine for Covid-19, is also being explored as a potential solution. This platform is expected to accelerate the production process, but the timeline for approval remains uncertain.
Transmission Dynamics and Historical Context
Ebola spreads through direct contact with bodily fluids, such as blood or saliva, and can enter the body via broken skin or mucous membranes. This mode of transmission has led to severe complications, including hemorrhagic fever and organ failure. The virus was first discovered in 1976 in what is now the DRC, with the initial outbreak linked to a bat as the likely source. Since then, it has evolved into a recurring threat, with the country experiencing its 17th Ebola outbreak. The current strain, Bundibugyo, has only caused two prior outbreaks—once in Uganda in 2007 and again in the DRC in 2012. In those instances, it resulted in approximately a third of infections being fatal.
Healthcare workers are among the most vulnerable to the virus, with several fatalities reported in the DRC. This has raised alarms about the safety of medical personnel and the need for better protective measures. Despite the arrival of personal protective equipment (PPE), some workers are still operating without adequate supplies. The scarcity of PPE has been a significant barrier to effective containment, with officials urging for more support to prevent further spread.
Experts are also grappling with the long-term implications of the outbreak. The initial case, a nurse in Bunia, was repatriated to Mongwalu, one of the two gold-mining towns where the majority of infections have been traced. The proximity of these communities to the epicenter suggests that economic and social factors may contribute to the virus’s transmission. Additionally, the delayed recognition of the outbreak has allowed it to progress before interventions could be fully implemented. This has led to a situation where the virus is already widespread, making control more difficult.
As the WHO continues to monitor the outbreak, the focus remains on both immediate response and long-term prevention. The organization is working closely with local and international partners to implement strategies that address the current crisis while preparing for future threats. With the possibility of a vaccine within nine months, the global health community is hopeful that a solution is on the horizon. However, the timeline for approval and distribution will depend on the success of clinical trials and the availability of resources.
In the meantime, the situation in the DRC is intensifying, with the eastern provinces of Ituri and North Kivu at the heart of the outbreak. The rapid spread of the virus has forced communities to adopt new behaviors, such as avoiding physical contact, to reduce risk. These measures, while effective, are difficult to sustain in the absence of clear information. Public health officials are now emphasizing the importance of communication and education to ensure that people remain informed and vigilant.
With the combined efforts of governments, organizations like MSF, and the WHO, there is a concerted push to contain the virus and protect vulnerable populations. The next nine months will be critical in determining whether this outbreak can be brought under control or if it will escalate further. As the world watches the developments, the resilience of healthcare workers and the adaptability of communities will play a key role in shaping the outcome of this public health challenge.